ICARES Medicus, Inc. (TPEX:6612)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
68.30
+0.20 (0.29%)
Apr 29, 2026, 1:30 PM CST
-31.39%
Market Cap 3.23B
Revenue (ttm) 1.13B
Net Income (ttm) 51.23M
Shares Out 47.52M
EPS (ttm) 1.08
PE Ratio 62.96
Forward PE n/a
Dividend 0.30 (0.44%)
Ex-Dividend Date Aug 22, 2025
Volume 8,420
Average Volume 21,269
Open 68.10
Previous Close 68.10
Day's Range 68.00 - 68.30
52-Week Range 66.00 - 118.64
Beta 0.31
RSI 41.40
Earnings Date Mar 26, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and l... [Read more]

Sector Healthcare
Founded 2011
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6612
Full Company Profile

Financial Performance

In 2025, ICARES Medicus's revenue was 1.13 billion, an increase of 31.54% compared to the previous year's 859.79 million. Earnings were 51.23 million, a decrease of -50.32%.

Financial Statements

News

There is no news available yet.